The US Food and Drug Administration has approved a landmark eye drop that uses a combined dose of medication to restore ...
Morning Overview on MSN
FDA clears 1st dual-action eye drop to fight age-related vision loss
Age-related near vision loss has long been treated as an inevitable annoyance of getting older, a slow erosion of clarity ...
The FDA approved a fixed-dose combination of carbachol and brimonidine tartrate for presbyopia, offering a noninvasive ...
The U.S. Food and Drug Administration has approved Yuvezzi (carbachol and brimonidine tartrate) ophthalmic solution 2.75%/0.1 ...
Combining two eye drops that have been on the market for at least 30 years each has earned Tenpoint Therapeutics an FDA ...
Eventually, you succumb to “trombone arm,” stretching your hands out as far as they will go, until finally, you admit defeat ...
If you purchased any of these eye drops, stop using them. To get a refund for your purchase, AvKare states that you must complete the "Quantity to Return" column and customer information block on its ...
Meta: Upneeq eye drops are the FDA-approved treatment for Acquired Ptosis aka low-lying eyelids. Since I have always looked a ...
The Food and Drug Administration (FDA) announced a nationwide recall of a popular single-use eye drop on December 23. Alcon Laboratories, maker of Systane eyedrops, voluntarily recalled one lot of ...
While eye drops may help alleviate some symptoms of diabetic retinopathy, they don’t target the underlying blood vessel damage in your retina. Retinopathy is a possible complication of diabetes. At ...
A chemical used in some over-the-counter eye drops may affect liver cells and be transformed to a PFAS-like substance. This is according to a new study from Örebro University published in Environment ...
The FDA approved Yuvezzi, an eye drop for the treatment of presbyopia, with broad U.S. availability expected in the second quarter, according to a press release from Tenpoint Therapeutics. Yuvezzi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results